• Hernia Mesh Lawyers: In their ongoing mission to help people injured by dangerous drugs and devices the Pradaxa Helpline has launched a Hernia Mesh Hotline. More and more people have been reporting complications from a hernia mesh surgery. ...
  • Texas Pradaxa Lawyer: Get Your Texas Pradaxa  Lawyer Texas Pradaxa Lawyer  Network has Texas Pradaxa  lawyers ready to help you if you have been injured by Pradaxa extensive bleeding in: Dallas, Houston, Abilene, Amarillo, Austin, Arlington,...
  • Xarelto Lawsuit Helpline | Xarelto Lawyers: Xarelto Lawsuit Helpline Get An Xarelto Extensive Bleeding Lawyer If you or a loved one took Xarelto for prevention of blood clots and pulmonary embolisms and this resulted in severe injury or death  contact  Xarelto L...

West Palm Beach IVC Filter Alert

Written by Xarelto Helpline on . Posted in Vena Cava Filter, Xarelto News

IVC Filters, Vena Cava Filters, Blood Clot Filter lawyers in West Palm Beach, Delray Beach, Boca Raton and Deerfield Beach are alerting seniors to the dangers of the Bard and Cook IVC Filters. IVC filters are implanted to capture blood clots and prevent them from causing pulmonary embolisms and strokes by lodging in the lungs or brain. However, IVC filters have some dangerous side effects and IVC Filter lawsuits are being filed. Complications include: vein and organ perforation, migration and breakage,  broken pieces of filters traveling  through the body causing organ damage. IVC filters are meant to be temporary. Risk of Adverse Events with Long Term Use According To The FDA [Posted 08/09/2010] AUDIENCE: Emergency Medicine, Surgery ISSUE: Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided. The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation. BACKGROUND: FDA reviewed the literature and is conducting quantitative decision analysis modeling to evaluate the change in the risk/benefit profile after retrievable IVC filter implantation over time. More information about FDA’s decision analysis model including risk/benefit implantation time frame suggestions will be made available in an update to this communication as well as in a future publication in a peer-reviewed medical journal. RECOMMENDATION: FDA recommends that implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from PE is no longer needed. FDA encourages all physicians involved in the treatment and follow-up of IVC filter recipients to consider the risks and benefits of filter removal for each patient. If a patient has a retrievable IVC filter that should be removed based on his or her individual risk/benefit profile, the primary care physician and/or those providing ongoing patient care should refer the patient for IVC filter removal when feasible and clinically indicated. If you or a loved one has been injured by  a Vena Cava Filter contact our IVC Filter Lawsuit Helpline today.  

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,